Truist Securities Lowers Inspire Medical Stock Rating Amid Coding Challenges
Truist Securities has downgraded Inspire Medical Systems stock from Buy to Hold and trimmed the price target from $120 to $96 following the company's loss of official usage rights for a key Medicare code. Despite these challenges, Inspire's financial health remains strong, supported by profitability and solid cash reserves. Further impacts stem fro…